ClearPoint Neuro CLPT Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | $872K+126% | $386K— | —— | ||
| $36.97M+17.8% | $31.39M+31.0% | $23.96M+16.6% | $20.55M+26.1% | ||
| $14.28M+16.4% | $12.27M+18.6% | $10.34M+47.3% | $7.02M+35.4% | ||
| $22.69M+18.7% | $19.12M+40.5% | $13.61M+0.6% | $13.53M+21.8% | ||
| 61.4%+0.5pp | 60.9%+4.1pp | 56.8%-9.0pp | 65.8%-2.3pp | ||
| $13.9M+12.1% | $12.39M+5.8% | $11.71M+7.5% | $10.89M+16.6% | ||
| $16.5M+37.6% | $11.99M+2.0% | $11.76M+22.3% | $9.61M+20.0% | ||
| $16.46M+13.7% | $14.48M+15.0% | $12.6M+34.6% | $9.36M+31.3% | ||
| -$24.16M-22.4% | -$19.73M+12.1% | -$22.45M-37.4% | -$16.33M-22.1% | ||
| -65.4%-2.5pp | -62.9%+30.8pp | -93.7%-14.2pp | -79.5%+2.6pp | ||
| —— | $518K— | —— | —— | ||
| —— | $1.39M— | —— | —— | ||
| -$146K-265% | -$40K-37.9% | -$29K-31.8% | -$22K+64.5% | ||
| -$25.49M-34.8% | -$18.9M— | —— | —— | ||
| $55K— | —— | —— | —— | ||
| -$25.54M-35.0% | -$18.91M+14.4% | -$22.09M-34.4% | -$16.44M-14.1% | ||
| -69.1%-8.8pp | -60.3%+32.0pp | -92.2%-12.2pp | -80%+8.4pp | ||
| -$0.91-30.0% | -$0.70+23.1% | -$0.91-33.8% | -$0.68-1.5% | ||
| -$0.91-30.0% | -$0.70+23.1% | -$0.91-33.8% | -$0.68-1.5% | ||
| 112.7M+4.8% | 107.5M+9.3% | 98.4M+2.1% | 96.3M+15.2% | ||
| 112.7M+4.8% | 107.5M+9.3% | 98.4M+2.1% | 96.3M+15.2% | ||
| -$146K-265% | -$40K-37.9% | -$29K-31.8% | -$22K+64.5% | ||
| -$24.16M-22.4% | -$19.73M+12.1% | -$22.45M-37.4% | -$16.33M-22.1% | ||
| -$23.35M-24.5% | -$18.75M+14.1% | -$21.82M-35.6% | -$16.09M-21.7% | ||
| -$23.35M-24.5% | -$18.75M+14.1% | -$21.82M-35.6% | -$16.09M-21.7% | ||
| -63.2%-3.4pp | -59.7%+31.3pp | -91.1%-12.8pp | -78.3%+2.8pp | ||
| -$24.16M-22.4% | -$19.73M+12.1% | -$22.45M-37.4% | -$16.33M-22.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is ClearPoint Neuro's revenue?
- ClearPoint Neuro (CLPT) generated $40.6M in revenue over the trailing twelve months, up 26.0% year over year.
- Is ClearPoint Neuro profitable?
- ClearPoint Neuro is not currently profitable: it reported a net loss of $29.1M over the trailing twelve months, a -71.6% net margin.
- What are ClearPoint Neuro's profit margins?
- Gross margin is 62.3% and operating margin is -65.2%, with a -71.6% net margin.
- What is ClearPoint Neuro's earnings per share?
- ClearPoint Neuro's diluted EPS over the trailing twelve months is $-1.01.
- Where does ClearPoint Neuro's income statement data come from?
- Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
